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Abstract
Streptococcus pyogenes is an important human pathogen and surface structures allow it to adhere to, colonize and invade
the human host. Proteins containing leucine rich repeats (LRR) have been indentified in mammals, viruses, archaea and
several bacterial species. The LRRs are often involved in protein-protein interaction, are typically 20–30 amino acids long and
the defining feature of the LRR motif is an 11-residue sequence LxxLxLxxNxL (x being any amino acid). The streptococcal
leucine rich (Slr) protein is a hypothetical lipoprotein that has been shown to be involved in virulence, but at present no
ligands for Slr have been identified. We could establish that Slr is a membrane attached horseshoe shaped lipoprotein by
homology modeling, signal peptidase II inhibition, electron microscopy (of bacteria and purified protein) and
immunoblotting. Based on our previous knowledge of LRR proteins we hypothesized that Slr could mediate binding to
collagen. We could show by surface plasmon resonance that recombinant Slr and purified M1 protein bind with high affinity
to collagen I. Isogenic slr mutant strain (MB1) and emm1 mutant strain (MC25) had reduced binding to collagen type I as
shown by slot blot and surface plasmon resonance. Electron microscopy using gold labeled Slr showed multiple binding
sites to collagen I, both to the monomeric and the fibrillar structure, and most binding occurred in the overlap region of the
collagen I fibril. In conclusion, we show that Slr is an abundant membrane bound lipoprotein that is co-expressed on the
surface with M1, and that both these proteins are involved in recruiting collagen type I to the bacterial surface. This
underlines the importance of S. pyogenes interaction with extracellular matrix molecules, especially since both Slr and M1
have been shown to be virulence factors.
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Introduction
Streptococcus pyogenes is an important human pathogen. It most
commonly causes throat and skin infections, such as pharyngitis
and impetigo [1]. It can also cause severe invasive diseases such as
sepsis, necrotizing fasciitis and toxic shock syndrome, as well as
complications post infection such as rheumatic fever and
glomerulonephritis [2]. Surface structures of S. pyogenes allow the
bacteria to adhere to, colonize and invade mucus membranes and
human skin. Some of these structures are M protein, M-like
proteins, collagen type I-binding protein (Cpa) and streptococcal
fibronectin-binding protein I (SfbI) [3,4].
Mammalian cells have a variety of ways to detect invading
pathogens and to alert the immune system. The best known are
the Toll-like receptors (TLR), which are transmembrane receptors
containing an extracellular leucine rich repeat (LRR) domain. It is
the LRR domain in TLRs that is responsible for recognizing
diverse microbial components [5]. More recently indentified
receptors involved in bacterial recognition are receptors with a
carboxyl-terminal LRR domain, a central nucleotide binding and
oligomerization domain (NOD). They are implicated in the
cytosolic detection of bacterial components, mediated through the
LRR domain [6,7]. LRR proteins are also involved in protein-
protein interactions such as signal transduction, cell adhesion and
apoptosis [8,9]. LRR proteoglycan decorin has been shown to
bind to fibrillar collagens. Other examples of LRR proteins are
proline arginine-rich end leucine-rich repeat protein (PRELP),
chondroadherin (CHAD) and biglycan [10,11].
LRRs are typically 20–30 amino acids long and the defining
feature of the LRR motif is an 11-residue sequence LxxLxLxxNxL
(x being any amino acid). The number of LRR repeats ranges
from 2 to 45 and they are divided into a conserved and variable
segment [12,13]. The conserved amino-terminal stretch of 9–12
amino acids forms the b-strand and the variable segment is a
carboxy-terminal stretch of 10–19 amino acids that varies in
length, sequence and structure. The arrangement of the repeats
results in a horseshoe-shaped structure with the b-sheet on the
concave side and the variable stretches on the convex side [14,15].
Several pathogenic bacteria, both Gram positive and Gram
negative express surface proteins with LRR regions. LRR proteins
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[15,16]. Internalins of Listeria monocytogenes are the most studied
bacterial proteins with LRR domains. There are at least 9 proteins
in this family and all have been implicated in the invasion of the
human cell [17]. The streptococcal leucine rich (Slr) protein is
predicted to be a lipoprotein attached to the cell membrane and
has been shown to be camouflaged for antibody recognition by the
M6 protein [18,19]. Antibodies against Slr are developed during a
S. pyogenes infection in humans and an S. pyogenes strain lacking Slr
had lower resistance against neutrophil phagocytosis in vitro and
was less virulent in a mouse model of infection [18,19]. Slr lacks a
LPXTG motif, which links Gram-positive proteins to the cell wall;
instead a TLIA lipobox is present and acts as a membrane
anchoring motif. The Slr protein is similar to virulence proteins of
the internalin family of L. monocytogenes but there are differences
between the proteins. The LRR region in Slr is located in the C-
terminal half of the molecule unlike the members of the internalin
family in which the LRR region is located in the N-terminal part
of the protein. At the end of the N-terminal region there are four
histidine triad motifs that are not present in the internalin family of
proteins.
Adherence of human pathogens to certain tissue components
might reflect preferences for specific sites of infection. Bacterial
adhesins that interact with extracellular matrix components such
as collagen, fibronectin, fibrinogen and laminin-related polysac-
charides have been identified for both Gram-negative and Gram-
positive bacteria. Groups A, B, C, D and G streptococci have all
been shown to exhibit collagen binding ability [20]. Protein FOG
is one of the proteins that recruit collagen type I in group G
streptococci [21]. For S. pyogenes, adhesion to collagen type IV by
surface protein M3 has been reported as well as binding to M-
negative strains [2,22]. Since Slr is a putative surface located
lipoprotein containing LRR motifs, we hypothesized that Slr could
mediate binding to collagen. In this study we present experimental
evidence that Slr is a surface attached lipoprotein containing LRR
regions. Furthermore, using electron microscopy of immunogold
labeled Slr and other experimental techniques, we were able to
show that Slr is a collagen I binding protein.
Materials and Methods
Reagents, bacteria and culture conditions
Bacteria and plasmids used in this study are described in
Table 1. The S. pyogenes strain of serotype M1 (AP1) and mutants
MB1 and MC25 were cultured in Todd-Hewitt broth (TH) (Difco,
Detroit, DI, USA) or TH broth with 0.2% yeast extract (THY)
(Oxoid LTD, Hampshire, UK) at 37uCi n5 %C O 2 atmosphere,
including 150 mg/ml kanamycin for growth of the mutants.
Collagen I was purchased from Sigma (St.Louis, MO, USA).
Antibodies used in this study were goat anti-rabbit IgG-peroxidase
labeled antibody (Bio-Rad, CA, USA) and rabbit anti-collagen I/
III antibody (Calbiochem, Darmstadt, Germany). The S. pyogenes
mutant strain MC25 used in this study was constructed as
previously described by Collin et al [23].
Generation of Slr mutant strain
A PCR product was generated from AP1 chromosomal DNA
using oligonucleotide primers 59-ATT-ATT-CTC-GAG-GGT-
CTA-TTG-TTA-TCA-T-39 and 59-TTG-ACT-AGA-TCT-
TAT-AAT-GGA-AGT-G-39 with XhoI and BglII sites. The XhoI
and BglII digested PCR fragment was ligated into XhoI and BglII
digested pFW13 and transformed into TOP10 chemically
competent cells (Invitrogen, Carlsbad, CA). Purified plasmids
were electroporated into competent AP1 cells as previously
described [24]. For preparation of competent AP1 cells, the
bacteria were cultured over night in THY broth, washed with
water and 0.5 M sucrose solution. The electroporator settings
were 2.3 kV, 3 mF, 800 Ohms. The electroporated cells underwent
phenotypic expression for 2 h in SOGAS solution at 37uCi n5 %
CO2. The AP1 recombinants were selected on THY-plates
containing 150 mg/ml kanamycin. All the S. pyogenes isolates
described in Table 1 were tested for the presence of the slr gene
using standard PCR. DNA was prepared by boiling single colonies
in 100 ml of distilled water followed by centrifugation at 10,0006g
for 5 min. One ml of supernatant was used as template for PCR
with an annealing temperature of 53uC using the oligonucleotide
primers 59-GCT-CCA-ACC-CCA-TTC-CC-ATC-39 and 59-
TCG-TGA-GCA-TGA-CCT-TCT-TCA-TC-39 generating an
1169 bp product.
Characterization of mutants by Western Blot
The S. pyogenes wild type strain AP1 and mutants MB1 and
MC25 were cultured in THY broth, including 150 mg/ml
kanamycin for growth of the mutants, at 37uCi n5 %C O 2
atmosphere. The bacterial pellets were resuspended in SDS-PAGE
sample buffer and separated by 10% SDS-PAGE and blotted to an
Immobilion-P
TM PVDF-membrane (Millipore, Bedford, MA)
according to Towbin et al [25]. After blotting, the membrane
was blocked in 15 ml PBS (140 mM NaCl, 30 mM KCl, 8 mM
Na2HPO4, 2 mM KH2PO4) containing 0.1% Tween 20 (PBST)
and 5% skim milk for 30 min at room temperature. After addition
of primary antibody from Slr and M1 whole rabbit antiserum at
dilution 1:1,000 and 1:20,000, the membrane was incubated at
37uC for 30 min in PBST and 5% skim milk. The filter was
washed three times for 5 min in PBST and incubated with goat
anti-rabbit IgG-peroxidase labeled antibody diluted 1:3,000 in
PBST and 5% skim milk. After incubation the filter was washed
three times in PBST and developed with SupersignalH West Pico
Chemiluminescent substrate (Thermo Scientific, Rockford, IL)
followed by visualization using a Chemidoc XRS imaging system
and Quantity One image analysis software (Bio-Rad).
Analysis of bacterial mutants and Slr by electron
microscopy
F(ab9)2 fragments of rabbit anti-Slr and anti-M1 IgG were
generated using the IgG specific streptococcal protease IdeS [26].
IgG from 2 ml Slr or M1 antiserum was adsorbed to 2 ml Protein
G Sepharose followed by washing with 865 ml PBS. 1 mg of
GST-IdeS in 1 ml PBS was added and incubated for 5 h in 20uC.
Filtrate was passed 5 times through Glutathione Sepharose (GE
Healthcare, Uppsala, Sweden) to remove GST-IdeS. Integrity and
purity of F(ab9)2 fragments were verified by SDS-PAGE and
protein concentration was determined using Advanced Protein
Assay Reagent (Cytoskeleton, Denver, CO) (data not shown). The
presence and location of individual Slr and M1 molecules on wild
type and mutant GAS was analyzed by negative staining and
transmission electron microscopy as described previously [27].
F(ab9)2 fragment samples were conjugated with, 15 nm for Slr and
10 nm for M1, colloidal thiocyanate gold [28]. Bacteria were
grown to Log phase (OD620=0.5), washed in 3610 ml TBS
(50 mM Tris-HCl, 150 mM NaCl, pH 7.4) and adjusted to 2610
9
colony forming units (cfu) per ml. The bacteria were mixed with
the F(ab9)2 -Au conjugates and incubated for 1 h at room
temperature at a 1:2 molar ratio. 5 ml aliquots were adsorbed
onto carbon-coated grids for 1 min, washed with two drops of
water, and stained on two drops of 0.75% uranyl formate. The
grids were rendered hydrophilic by glow discharge at low pressure
in air. Specimens were observed in a JEOL JEM 1230 electron
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Strain/plasmid M type Genotype Characteristics Slr gene
1 Reference or source
Bacteria
Streptococcus pyogenes
AP1 1 Wild type M1 serotype + WHO Prague collection
2
MC25 1 emm1::Km M1 lacking mutant + [23]
MB1 1 slr::Km Slr lacking mutant - This study
SF370 1 emm1 M1 serotype + [37,49]
AP4 4 emm4 M4 serotype + WHO Prague collection
AP6 6 emm6 M6 serotype + WHO Prague collection
AP12 12 emm12 M12 serotype + WHO Prague collection
AP15 15 emm15 M15 serotype + WHO Prague collection
AP23 23 emm23 M23 serotype + WHO Prague collection
AP46 46 emm46 M46 serotype + WHO Prague collection
AP47 47 emm47 M47 serotype + WHO Prague collection
AP53 53 emm53 M53 serotype + WHO Prague collection
Manfredo 5 emm5 M5 serotype + [50]
3686-98 1 emm1 M1 serotype + Center for disease control
3
3688-98 2 emm2 M2 serotype + Center for disease control
3671-98 3 emm3 M3 serotype + Center for disease control
3670-98 4 emm4 M4 serotype + Center for disease control
3667-98 5 emm5 M5 serotype + Center for disease control
3693-98 6 emm6 M6 serotype + Center for disease control
3261-98 9 emm9 M9 serotype + Center for disease control
3904-98 11 emm11 M11 serotype + Center for disease control
3664-98 12 emm12 M12 serotype + Center for disease control
3258-98 18 emm18 M18 serotype + Center for disease control
3913-98 19 emm19 M19 serotype + Center for disease control
3858-98 22 emm22 M22 serotype + Center for disease control
SS-987 24 emm24 M24 serotype + Center for disease control
3272-98 28 emm28 M28 serotype + Center for disease control
3274-98 49 emm49 M49 serotype + Center for disease control
189-98 55 emm55 M55 serotype + Center for disease control
SS-790 57 emm57 M57 serotype + Center for disease control
978-97 60 emm60 M60 serotype + Center for disease control
86-858 12 emm12 M12 serotype + [51]
KTL3 1 emm1 M1 serotype + Finnish Institute for Health
KTL9 28 emm28 M28 serotype + Finnish Institute for Health
Escherichia coli
TOP10 recA1 endA1 hsdRMS Cloning strain Invitrogen
BL21(DE3)pLysS Protein expression strain Novagen
pGEX-6P-1 GST fusion vector GE Healthcare
pGEXslr For expression of GST-Slr fusion protein This study
pFW13 kan
R Streptococcal suicide vector [52]
pMB01 kan
R slr knockout plasmid construct This study
pCRH2.1-TOPOH kan
R,a m p
R Cloning vector Invitrogen
1Presence of the slr gene was determined using PCR as described in Material and Methods.
2WHO Collaborating Center for Reference and Research on Streptococci, Institute of Hygiene and Epidemiology, Prague, Czech Republic.
3National Center for Disease Control reference codes.
doi:10.1371/journal.pone.0020345.t001
The Streptococcal Lipoprotein Slr Binds Collagen I
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e20345microscope operated at 80 kV accelerating voltage, and images
were recorded with a Gatan Multiscan 791 CCD camera. A 5 ml
aliquot of Slr (1 mg/ml) in TBS buffer (50 mM Triss-HCl,
150 mM NaCl, pH 7.4) was adsorbed onto carbon-coated grids
and visualized by electron microscopy as previously described.
Expression pattern of Slr and M1 protein
The S. pyogenes wild type strain AP1 was cultured in THY broth,
at 37uCi n5 %C O 2 atmosphere. Growth was recorded hourly by
measurement of OD620 and plotted in KaleidaGraph (Synergy
Software, Reading, PA). Samples were collected hourly; Slr and
M1 Western blot on cell extracts was performed as described
above.
Recombinant expression of Slr and purification of M1
protein
Slr was expressed in Escherichia coli using the GST Gene Fusion
System (GE Healthcare). A 2337 base pair slr PCR product was
amplified from S. pyogenes AP1 genomic DNA using primers 59-
ACT-TTG-GGA-TCC-TGT-CAA-TCA-CGA-39 with a BamHI
site (underlined) and 59-TCT-TAG-CTC-GAG-TTA-GTC-
AGC-ATG-39 with an XhoI site (underlined). This fragment was
digested with BamHI and XhoI, ligated into pGEX-6P-1 generating
plasmid pGEXslr, that was used to transform E. coli BL21(DE3)-
pLys. pGEXslr/BL21(DE3)pLys was induced with 0.1 mM
isopropyl b-D-thiogalactopyranoside and GST-Slr was purified
using Glutathione-Sepharose (GE Healthcare) according to
manufacturer’s instructions. Purified GST-Slr was used for
immunization of rabbits according to standard protocols [29].
The GST tag was removed from GST-Slr by on-column cleavage
using Precission protease according to manufacturer’s instructions
(GE Healthcare). M1 protein was purified from culture superna-
tants from MC25 using affinity chromatography and anti-M1
rabbit antiserum was generated as previously described [23,29].
Sequence analysis and homology modeling of Slr
A homology model of Slr was generated using Multiple
Mapping Method with Multiple Templates (M4T) (http://www.
fiserlab.org/servers/m4t) [30] (using Internalin A (PDB 1O6V)
[31] as a template. The Slr model was visualized using VMD 1.8.6
(http://www.ks.uiuc.edu/Research/vmd/) [32] and high resolu-
tion images were generated using the Tachyon ray tracer [33].
Lipoprotein analysis using globomycin
AP1 bacteria were cultured in TH over night supplemented
with 0, 12.5, 25 and 50 mg/ml of the signal peptidase II inhibitor
globomycin similarly to what has been described for S. equisimilis, S.
equi and S. zooepidemicus [34,35]. Bacteria from 5 ml cultures were
pelleted by centrifugation and resuspended in 200 ml PBS.
Bacteria were lysed by addition of 100 U of the bacteriophage
lysin PlyC [36] for 10 min at room temperature followed by
addition of a final concentration of 25 mg/ml of ribonuclease A
and deoxiribonuclease (Sigma) and incubation for 10 min at room
temperature. Samples were centrifuged for 10 min at 14,0006g at
4uC. Pellets were resuspended in SDS-PAGE sample buffer and
separated on 10% SDS-PAGE followed by transfer to PVDF
membranes and anti-Slr Western blot as described above.
Absorption of collagen type I to S. pyogenes strains
The strains AP1, MB1 and MC25 were grown in THY to
OD620=0.8, with 150 mg/ml kanamycin for growth of the
mutants, at 37uCi n5 %C O 2 atmosphere. The bacteria were
washed with PBST and diluted to 2610
9 cfu/ml solution. 200 ml
of the bacterial solution were incubated with 100 mg collagen I for
one hour at room temperature. Aliquots of the solution were taken
for electron microscopy visualization as previously described in
Bober et al [27]. The bacterial solution was washed three times
with PBST and the bound collagen was eluted from bacterial
surface by incubation with 0.1 M glycine, pH 2.0 for 20 min. The
bacteria were removed by centrifugation, 15006g for 10 minutes,
and the supernatant was neutralized by addition of 1 M Tris base.
15, 10 and 5 ml of the samples were immobilized on a PVDF
membrane using the Milliblot-D system (Millipore). The mem-
brane was blocked in 5 ml PBST and 5% skim milk for 30 min at
room temperature. After addition of rabbit anti-collagen I/III
antibody (Calbiochem, Darmstadt, Germany) diluted 1:60 in
PBST and 5% skim milk, the membrane was incubated at 37uC
for 30 min. The filter was washed three times for 5 min in PBST
and incubated with goat anti-rabbit IgG-peroxidase labeled
antibody (Bio-Rad) diluted 1:3,000 in PBST and 5% skim milk.
After incubation, the filter was washed three times in PBST and
visualized as above. The samples were also analyzed by separation
on a reducing 3–12% SDS-PAGE gel and stained with Coomassie
Brilliant Blue.
Radiolabeling of collagen type I and Slr
Radioactive iodine (
125I) labeling was performed using IODO-
BEADS (Pierce, Rockford, IL, USA) and done according to the
manufacturer’s instructions. Unbound iodine was removed on a
PD-10 column (Amersham Biosciences, Uppsala, Sweden) in PBS
buffer containing 0.05% Tween 20 and 0.002% sodium acide
(PBSAT). Fractions of 500 ml were collected and radioactivity was
measured using a Wallac Wizard 1470 automatic gamma counter.
The fraction containing the radiolabeled protein was stored at
+4uC until further usage.
In vitro binding studies
The strains AP1, MB1 and MC25 were grown in THY to
OD620=0.8, with 150 mg/ml kanamycin for growth of the
mutants, at 37uCi n5 %C O 2 atmosphere. The bacteria were
washed with PBSAT and diluted to 2610
9 cfu/ml solution. 250 ml
of the bacterial solution were incubated with approximately 100
0000 counts per minute (cpm)
125I labeled collagen I for 30 min at
room temperature. The unbound collagen was removed by
centrifugation, 15006g for 10 minutes, and the pellet was
measured for radioactivity using a Wallac Wizard 1470 automatic
gamma counter. Percent of binding was calculated with Kaleida-
Graph (Synergy Software) and values were illustrated in a dot plot.
Experiments were performed in quadruples at three independent
time points.
Collagen I, non-denatured and denatured with guanidine
hydrochloride was applied directly onto a PVDF membrane using
the Milliblot-D system (Millipore). The membrane was washed
twice for 30 min in PBS containing 0.25% Tween 20 and 2%
bovine serum albumin, incubated with
125I-Slr overnight at 4uC,
and washed three times for 20 min in blocking buffer as described
above. Signals of bound ligand were analyzed by phosphoimaging
in a Fujix BAS 2000 Bioimaging analyzer (Fujifilm Sverige AB,
Stockholm, Sweden).
The presence and location of individual Slr molecules on
monomeric and fibrillar collagen I was analyzed by gold labeling,
negative staining and transmission electron microscopy as
described above.
Surface plasmon resonance (SPR) interaction analysis
Collagen I, diluted to 10 mg/liter in 10 mM sodium acetate
(pH 4), was immobilized via amine coupling to CM3 sensorchip
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1500 RU). Briefly, Collagen was mixed with freshly prepared
100 mM N-hydroxysuccinimide and 400 mM N-ethyl-N’-(di-
methylaminopropyl)carbodiimide in equal volumes, and capping
of unreacted carboxymethyl sites was achieved by a 1 M
ethanolamine (pH 8) injection. A flow chamber subjected to the
immobilization protocol but without any addition of protein was
used as control (blank) for each experiment. Slr and M1 proteins
respectively, were sequentially diluted 2-fold in running buffer
(10 mM HEPES, 150 mM NaCl, and 0.005% Surfactant P20 (GE
Healthcare) pH 7.5) and injected over the collagen surface starting
at 500 nM and 35 ml/min. Bacterial cell suspensions were diluted
2-fold into PBS for injections in PBS in sequence starting from
2610
9 cfu/ml solution. Binding was monitored in a BIAcore 2000
instrument. Between experiments, the collagen surfaces were
strictly regenerated with multiple pulses of 2 M NaCl and 1.5 M
glycine-HCl pH 2.0 followed by an extensive wash procedure
using running buffer or PBS, respectively. After x-axis and y-axis
normalization of obtained data, the blank bulk refraction curves
from the control flow chamber of each injected concentration or
experiment were subtracted. Binding curves were displayed and
where applicable, the association (Ka) and dissociation (Kd) rate
constants were determined using the BIA Evaluation 4.1 software
and its equation for 1:1 Langmuir binding.
Results
Slr is a horseshoe shaped LRR lipoprotein
The slr gene encoding the S. pyogenes LRR protein Slr is present
in 32/32 strains of 24 different M serotypes as determined by PCR
(Table 1) and is also present in all currently sequenced S. pyogenes
genomes. The slr gene in strain AP1 was cloned and sequenced
using oligonucleotide primers based on the genome sequence from
the M1 strain SF370 (Accession no. NC_002737) [37]. Sequenc-
Figure 1. Characteristics of the Slr protein. A: Schematic comparison of the InlA from L. monocytogenes and Slr. The identity and similarity
between the two LRR regions are stated. The cell wall anchoring motif for InlA and the signal peptide II recognition motif for Slr are indicated as well
as the histidine triad motifs. B: Sequence alignments of the two groups of LRRs (A and B repeats) in Slr and comparison of the LRR consensus
sequences of Slr and InlA.
doi:10.1371/journal.pone.0020345.g001
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protein that is 99% identical to the predicted Slr protein from
SF370. The sequences of the Slr from AP1 and the corresponding
gene slr, have been deposited in Genbank under the accession
no. HQ908654. Slr contains a 21 amino acid putative N-terminal
signal sequence ending with the amino acid sequence TLIA. This
is the recognition sequence for signal peptidase II that allows for
lipid modification of the resulting amino-terminal cysteine and
insertion into the cellular membrane. In between amino acid 22
and 421 are four histidine triad motifs, that are not present in InlA
of L. monocytogenes. There are 13 LRRs in Slr spanning over amino
acid numbers 421–705 forming the b-sheets compared to 15
LRRs in InlA. The carboxyl terminal end of Slr contains histidine
rich repeat sequences, but lacks a cell wall anchoring motif, while
InlA carries a classical LPtTG cell wall anchoring motif
(Figure 1A). The LRR in Slr resembles the consensus motif of
the LRR region in InlA (Figure 1B). To confirm the horseshoe
shape of the protein, Slr was visualized by electron microscopy.
The Slr is pointed out by arrows and the shape is well visible
supporting a horseshoe like conformation of Slr (Figure 2A).
Figure 2. Visualization and confirmation of the LRR lipoprotein Slr. A: Slr protein visualized by electron microscopy showing the typical
horseshoe shape of a LRR protein. Scale bar =25 nm. B: a homology model of Slr using InlA as the template. The 11 LRRs forming b-sheets in yellow,
a2helices in blue, and loops in turquoise. C: SDS-PAGE analysis of recombinantly expressed GST-Slr and Slr with the GST tag cleaved off. D: Western
blot analysis, using anti-Slr antibodies, of bacterial cell extracts from AP1 bacteria grown in the presence of increasing amounts of the signal
peptidase II inhibitor globomycin as indicated.
doi:10.1371/journal.pone.0020345.g002
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supported the protein’s structure. The modeled LRRs forming the
b-sheets (blue) are suggested to be the protein-protein interaction
sites (Figure 2B).
Slr is a surface lipoprotein
The Slr protein was expressed in E. coli using the GST Gene
Fusion system and was used in several in vitro experiments (See
Material and Methods). GST-Slr and Slr were separated on a
SDS-PAGE for size and purity control. The GST-Slr has an
apparent size of 110 kDa and Slr of approximately 85 kDa
(Figure 2C). To confirm that Slr is a lipoprotein, a globomycin
inhibition assay was performed. The maturation of lipoproteins is
governed by signal peptidase II that removes signal peptides in the
NH2-terminal signal sequence. This step is inhibited by globomy-
cin, resulting in a surplus of signal peptides and thus an increased
molecular size (Figure 2D), confirming that Slr is a lipoprotein. To
investigate the role of Slr on the surface of S. pyogenes,w e
constructed a Slr mutant by single crossover mutagenesis of the
AP1 strain of M1 serotype. A 505 bp promotorless fragment of the
slr gene was cloned into multiple cloning site I of pFW13, resulting
in vector pMB01 (Figure 3A). One mutant strain denoted MB1
was chosen for further analysis. Correct insertion of pMB01 was
confirmed by PCR using gene- and plasmid specific primers
(Figure 3A, primer 1–4, data not shown). To confirm slr disruption
in MB1 and the Slr and M1 expression in AP1 and MC25, protein
extracts from AP1, MB1 and MC25 cell pellets were analyzed by
immunoblotting using anti-Slr and anti-M1 antibodies. A strong
signal was detected in the AP1 pellet for both Slr and M1 protein.
The only detectable signal in MB1 was for the M1 protein while in
MC25 only Slr expression was detected (Figure 3B). Further
mutant strain analysis and surface protein localization was done
using gold labeled F(ab’)2 fragments of anti-Slr (small gold) and
anti-M1 (large gold) IgG. The F(ab’)2 fragments were incubated
with wild type and mutant strains and analyzed by negative
staining and transmission electron microscopy. The AP1 strain,
expressing both Slr and M1 protein, bound both M1 and Slr
antibodies simultaneously, (Figure 3C) whereas the mutant MB1
strain only showed binding of M1 antibodies verifying that the Slr
protein is not expressed on the surface (Figure 3C). The mutant
Figure 3. Slr gene disruption, mutant strain analysis and protein localization by electron microscopy. A: Schematic representation of
the mutagenesis strategy used to disrupt slr in S. pyogenes strain AP1. B: SDS-PAGE and Western blot analysis, using antibodies against Slr and M1, of
bacterial cell extracts of the mutant strains MB1 and MC25, and wild type bacteria AP1. C: Wild type strain AP1, mutant strain MB1 and mutant strain
MC25 incubated with gold labeled F(ab’)2 fragments of anti-Slr (small gold particles) and anti-M1 (big gold particles) IgG. The dots represent binding
of the F(ab’)2 fragments to the Slr and M1 protein on the bacterial surface. Arrowheads without arrows indicate binding of anti-Slr antibodies, and
complete arrows indicate binding of anti-M1 antibodies in all three panels. Scale bar =100 nm.
doi:10.1371/journal.pone.0020345.g003
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the M1 protein is not present on the bacterial surface (Figure 3C).
The expression pattern of Slr and M1 was investigated in the wild
type strain AP1. The growth was plotted as OD620 versus the
incubation time (Figure 4A), and samples were taken for Western
blot analysis. Slr protein can be detected from hour 6 (approx.
OD620=0.4) and declines at hour 9 (approx. OD620=0.8), while
M1 can be detected from hour 2 (approx. OD620=0.05)
(Figure 4B) and starts to be degraded at hour 7 (data not shown).
Taken together, these results indicate that Slr is an abundant
membrane bound lipoprotein that is co-expressed on the surface
with the M1 protein in early stationary growth phase.
Slr and M1 binds to collagen type I
Previous results implicated that M proteins can interact with
collagens (data not shown). Since it has been stipulated that LRRs
have collagen binding capacity and since Slr is co-expressed with
M protein on the bacterial surface there are reasons to investigate
whether Slr can contribute to the collagen binding capacity of S.
pyogenes. Therefore, we analyzed a possible Slr- collagen interac-
tion. Wild type AP1 (expressing both M protein and Slr), mutant
strain MB1 (lacking Slr protein), and MC25 (lacking M1 protein)
bacteria were incubated with collagen I and the bound collagen
was eluted with low pH glycine. The eluted proteins were
immobilized on a PDVF membrane and anti-collagen Western
blot was performed. The wild type AP1 strains exhibited strongest
binding ability towards collagen I, while MB1 and MC25 strain
showed diminished binding capacity (Figure 5A). The eluted
collagen I from the AP1, MB1 and MC25 strains was also
separated on 3–12% SDS-PAGE with collagen I as a standard and
similar results could be observed as for anti-collagen Western blot,
with AP1 showing a higher binding of collagen I than both MC25
and MB1 (Figure 5B). In order to further establish the collagen
binding capacity of strains AP1, MB1 and MC25, a binding assay
with radiolabeled collagen I was performed. The strains were
incubated with
125I labeled collagen I, unbound collagen was
removed by centrifugation and the radioactivity value of bound
collagen was measured. All strains exhibited binding toward
collagen I with the binding capacity of 36.8% for AP1, 36.1% for
MB1 and 33.2% for MC25 (Figure 5C). The binding of collagen
to the bacterial strains was also visualized by electron microscopy,
where association of collagen I could be observed for all three
strains with a tendency of less accumulation in MB1 and MC25
(Figure 5D). To determine the influence of collagen denaturation
Figure 4. Growth curve and expression pattern of Slr and M1 protein in S. pyogenes strain AP1. A: Growth curve of S. pyogenes wild type
strain AP1 growth in THY medium over time. B: Western blot analysis of Slr and M1 protein expression in strain AP1 over 9 hours of growth.
doi:10.1371/journal.pone.0020345.g004
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guanidine hydrochloride-denatured collagen I was examined in
a slot blot experiment. The same procedure was used to determine
that the binding was not caused by the GST-tag on Slr. The slot
blot experiment showed no interaction between collagen I and the
GST-tag (data not shown). The radiolabeled Slr bound to both
collagen preparations in a similar manner (Figure 6A). Further in
vitro interaction between Slr and both monomer and fibrillar
collagen I was investigated. Gold labeled Slr (the dots) and
monomer collagen I show four binding sites. The dots are bound
to C- and N terminal as well as 70 respectively 100 nm further in
on the collagen (Figure 6B, panel I). More detailed analysis is
Figure 5. Absorption of collagen type I to S. pyogenes strains. A: After incubation of mutant strains MB1, MC25 and wild type AP1 strain with
collagen I, low pH eluates from bacteria were immobilized on a PVDF membrane and detected using anti-collagen antibodies. The amount of
collagen I eluate applied on the membrane is indicated to the left. B: The bacterial eluates described in 4A were separated on SDS-PAGE and stained
with Coomassie Brilliant Blue. Visible are the a1 (134 kDa) and a2 (130 kDa) chains indicated with arrows. C: Binding in percentage of
125I labeled
collagen I to the bacterial strains AP1, MB1 and MC25. Experiments were performed in quadruples at three independent time points. D: Interaction
between S. pyogenes strains and monomeric collagen. Collagen I was incubated with AP1, MB1 and MC25 and visualized by electron microscopy.
Arrows point to collagen I monomers. Scale bar =100 nm.
doi:10.1371/journal.pone.0020345.g005
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fibril is composed of triple helices overlapping each other, resulting
in a variation of triple helical thickness in the molecule. The short
span between light strands represents the overlap region where the
collagen triple helices overlap each other, while the dark span
represents the gap region where the gap between collagen helices
occurs. Binding can be observed in both regions, but is mostly
concentrated to the overlap region (Figure 6B, panel II). These
experiments were also executed with gold-labeled GST. There was
no interactions between GST and monomeric or fibrillar collagen
I (data not shown). The binding of Slr and M1 protein as well as
the AP1, MB1 and MC25 strains to collagen I was investigated
using surface plasmon resonance. Slr and M1 showed a dose-
dependent binding to collagen I with a KD of 12 nM and 54 nM,
respectively (Figure 7A and B). The bacterial strains AP1, MB1
and MC25 also showed a dose-dependent binding to collagen I
(Figure 7C–E). Taken together, these results suggest that both Slr
and M1 protein can bind collagen I, both when in purified form
and in a bacterial surface context. Slr has a somewhat higher
affinity towards collagen I than M1.
Discussion
S. pyogenesis a human pathogen responsible for a variety of diseases,
from common infections to life-threatening conditions. One of the
moststudied virulence factors of S. pyogenes i st h ec e l lw a l la n c h o r e dM
protein. It is involved in adherence to human epithelial cells, such as
buccal cells and epidermal keratinocytes [38,39]. The M protein is
also intimately linked to antiphagocytic properties and intracellular
survival in phagocytic cells [40,41]. Of particular interest for the
present study is that the M6 protein present on the surface of S.
pyogenes of M6 serotype has been suggested to camouflage the LRR
lipoprotein Slr from Slr antibody recognition [19].
Lipoproteins from Gram-positive bacteria are not as well
studied as cell wall anchored proteins, but several recent studies
have suggested that lipoproteins also are important for immune
evasion and adherence during colonization and infection.
Furthermore, several lipoproteins have shown promise as vaccine
candidates [42]. Previously described lipoproteins of S. pyogenes are
linked to metal transport as acquisition, most of them belong to
ABC transport systems and some have been shown to be virulence
factors in animal models of infection [43,44,45,46].
Proteins containing LRRs vary widely in functions and are
found in both prokaryotes and eukaryotes, but the known bacterial
LRR proteins, especially from Listeria species, are important
virulence factors that mediate adhesion and cellular invasion
through protein-protein interactions [17]. The slr gene encoding
Slr can be found in all 32 strains of 23 different M serotypes S.
pyogenes used in this study, as well as in all currently sequenced S.
pyogenes genomes. The apparent conservation of the slr gene, the
previous finding that patients with S. pyogenes infections seroconvert
to the Slr protein and the fact that Slr negative mutants are
attenuated in animal model and contribute to phagocytosis
resistance [18], warrant further investigation of the function of
Slr and possibly also exploration of Slr as a vaccine candidate.
Slr and M1 protein expression on the bacterial surface reach
their peaks at different time points during the logarithmic growth
phase and M1 starts to be degraded before Slr. However, during a
substantial amount of time in late logarithmic growth phase, both
proteins are present at the bacterial surface. This expression
pattern could be similar in an in vivo situation, where Slr and M1
surface exposure results in optimal adherence to host tissue. Direct
binding experiments indicate that Slr binds strongly to collagen I,
both in native and denatured form. This could suggest a fairly
limited site of interaction and/or a protein-protein interaction that
Figure 6. Binding of Slr to immobilized collagen I. A: Collagen I denatured with 4 M guanidine hydrochloride (+) and non-denatured collagen I
(2) were applied to a PVDF membrane and incubated with radiolabeled Slr. The amount of collagen is indicated to the right. B: Binding of gold
labeled Slr (the dots) and collagen I using electron microscopy. The dots are bound to C- and N terminal as well as 70 respectively 100 nm further in
on the monomeric collagen I (panel I). The short span between light strands represents the overlap region, whiles the dark span represents the gap
region on a collagen I fibril. Binding can be observed in both regions, but is mostly concentrated to the overlap region (panel II). Scale bar =100 nm.
doi:10.1371/journal.pone.0020345.g006
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In vitro binding assay with the wild type and mutant strains showed
that elimination of either Slr or the M1 protein on the bacterial
surface did not have a major affect on the strains’ total capacity to
bind collagen I. A similar binding pattern of Slr and M1 toward
collagen could also be observed in direct binding assays, leading to
a conclusion that both proteins can use collagen as a ligand.
Interestingly, we did not observe that M1 protein inhibited the
binding of gold-labeled Slr antibodies to Slr on the bacterial
surface as previously described for the M6 protein [19]. In fact,
gold-labeled anti-M1 and anti-Slr antibodies could bind simulta-
neously to the bacterial surface (Fig. 3C). This observation, in
combination with observed collagen binding to both proteins on
the surface of the bacteria, suggest that under the conditions
studied here, M1 and Slr are simultaneously accessible for some
protein-protein interactions on the bacterial surface. On the other
hand, elimination of either Slr or the M1 protein from the
bacterial surface might reveal additional binding sites toward
collagen I on the remaining protein in concordance with the
camouflaging described by Waldemarsson et al [19]. This might
Figure 7. Surface plasmon resonance interaction analysis. The binding of Slr and M1 protein, the wild type strain AP1, and mutant strains MB1
and MC25 strains to immobilized collagen I was investigated using surface plasmon resonance. Binding curves are displayed and, the association (Ka)
and dissociation (Kd) rate constants were determined. A–B: Slr and M1 proteins were diluted 2-fold in running buffer and injected over the collagen
surface starting at 500 nM and 35 ml/min. The proteins displayed a dose-dependent binding to collagen I with a KD of 12 nM for Slr and 54 nM for M1
protein. C–E: Bacterial cell suspensions were diluted 2-fold into PBS for injections sequences starting from 2610
9 cfu/ml solution.
doi:10.1371/journal.pone.0020345.g007
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binding capacity of the Slr and M1 mutants compared to the wild
type strain.
Another feature of Slr are the four histidine triad motifs in the
N-terminal part of the molecule, which are absent in InlA of L.
monocytogenes. Such motifs have been identified in four proteins of
Streptococccus pneumoniae and might be involved in metal or
nucleoside binding [47]. Furthermore, such histidine triad proteins
in S. pneumoniae have been shown to alter complement deposition of
the bacterial surface [48]. Therefore, enzymatic or other functions
than collagen binding of Slr, cannot be excluded.
In conclusion, we have established that Slr is an abundant
membrane bound horseshoe shaped LRR lipoprotein from S.
pyogenes that, both alone and in concert with M1 protein, interacts
strongly with collagen I. The multiple interactions with collagen I
through Slr and M protein, indicate that collagen binding is an
important feature of S. pyogenes. Therefore, further studies
elucidating the regulation of, and possible inhibition/co-operation
between Slr and M proteins will be important in understanding
how S. pyogenes interacts with the extracellular matrix during
colonization and infection.
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